<--- Back to Details
First PageDocument Content
PD-L1 / Immunology / Response Evaluation Criteria in Solid Tumors / Biomarker / Cytokine / Immunotherapy / Ipilimumab / B7 / Medicine / Biology / PD-1
Date: 2014-05-13 14:32:18
PD-L1
Immunology
Response Evaluation Criteria in Solid Tumors
Biomarker
Cytokine
Immunotherapy
Ipilimumab
B7
Medicine
Biology
PD-1

Predictors of Survival: MSKCC Data Base*

Add to Reading List

Source URL: www.euikcs.com

Download Document from Source Website

File Size: 1,51 MB

Share Document on Facebook

Similar Documents

CD274 (PD-L1)-Expression in colorectal cancer

DocID: 1usCQ - View Document

COMBINATION OF A GLYCOMIMETIC ANTAGONIST TO E-SELECTIN AND CXCR4, GMI-1359, WITH AN ANTI-PD-L1 ANTIBODY ATTENUATES REGULATORY T CELL INFILTRATION AND ACCELERATES TIME TO COMPLETE RESPONSE IN THE MURINE CT26 TUMOR MODEL W

DocID: 1ufHd - View Document

Nordic immunohistochemical Quality Control Institute of Pathology, Aalborg University Hospital, Ladegaardsgade 3, P.O.Box 561, DK-9100 Aalborg, Denmark Assessment Run C1 – PD-L1 Aalborg, Dear participant

DocID: 1u90w - View Document

T cells / Immune system / Medicine / Biology / Immunology / Genetics / Programmed cell death protein 1 / PD-L1 / CRISPR / T helper cell / Chimeric antigen receptor / LAG3

Successful Generation of CAR+PD-1- Primary T Cells Using Cas9-Mediated Genome Editing G. Grant Welstead1*, Justin Fang1, Chris Nye2, Frank Buquicchio1, McKensie Collins1, Will Selleck1, Eugenio Marco1, Hari Jayaram1, Ru

DocID: 1qiNJ - View Document

Immunology / Immune system / T cells / Interleukins / Programmed cell death protein 1 / PD-L1 / Immunotherapy / CD8 / IMP321 / Interleukin 21

Microsoft PowerPoint - AM0010-001 TIP Mayfinal

DocID: 1pufE - View Document